$NVAX News

Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know

What Novavax Doubters Overlooked

Is Novavax (NVAX) Fully Priced Relative To Its Sales Base?

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know

3 Reasons NVAX is Risky and 1 Stock to Buy Instead

Novavax (NVAX) Stock Declines While Market Improves: Some Information for Investors

Shah Capital Cuts Novavax Stake To 6.39%, Sells 2.87M Shares At Average Price Of $11.35/Share, Restructures Holdings Into Family Office

Citigroup Maintains Sell on Novavax, Raises Price Target to $8

Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know

Novavax (NVAX) Stock Could Be Above Fair Value As Plague Fears Fade

Should Novavax’s Headline-Driven Volatility Around Russia Health Scare Require Action From NVAX Investors?

Novavax: Vaccine Maker Sees Momentum In 2026, But Growth Story Holds Fundamental Risks

Transcript: Novavax Q2 2026 Earnings Conference Call

Novavax (NVAX) Stock Sinks As Market Gains: Here's Why

Novavax Stock Falls Back: What's Going On?

Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?

Novavax (NVAX) Rises As Market Takes a Dip: Key Facts

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know